Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benza

Showing results (321-330 of 362) with videos related to

Pageof 37
Sort By:
Pulmonary Circulation|May 24, 2023
The heart of the matter: Right heart imaging indicators for treatment escalation in pulmonary arterial hypertensionPaul Forfia, Raymond Benza, Michele D'Alto, et al.
Heart (British Cardiac Society)|February 14, 2023
Pulmonary artery compliance in different forms of pulmonary hypertensionAmber McCormick, Amita Krishnan, David Badesch, et al.
Chest|June 6, 2021
Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry: Enrollment Characteristics and 1-Year Follow-upKim M Kerr, C Greg Elliott, Kelly Chin, et al.
Chest|August 18, 2024
Equivalency of Multiple Biomarkers to Clinical Pulmonary Arterial Hypertension Survival Risk ModelsMegan Griffiths, Catherine E Simpson, Jun Yang, et al.
Vascular Pharmacology|September 12, 2024
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensusGiovanna Manzi, Raymond L Benza, Paola Argiento, et al.
Chest|September 30, 2019
Retrospective Validation of the REVEAL 2.0 Risk Score With the Australian and New Zealand Pulmonary Hypertension Registry CohortJames J Anderson, Edmund M Lau, Melanie Lavender, et al.
Pulmonary Circulation|November 26, 2020
Residence at moderately high altitude and its relationship with WHO Group 1 pulmonary arterial hypertension symptom severity and clinical characteristics: the Pulmonary Hypertension Association RegistryShoaib Fakhri, Kelly Hannon, Kelly Moulden, et al.
Circulation|August 25, 2022
Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial HypertensionSamuel B Brusca, Jason M Elinoff, Yvette Zou, et al.
Journal for Immunotherapy of Cancer|August 25, 2021
Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphomaJonathan E Brammer, Zachary Braunstein, Aashish Katapadi, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2026
Circulating Biomarker Results From a Phase 2 Study of Seralutinib in Pulmonary Arterial HypertensionRobin Osterhout, Athénaïs Boucly, Raymond L Benza, et al.
Pageof 37

Showing results (321-330 of 362) with videos related to

Sort By:
Pageof 37
Pulmonary Circulation|May 24, 2023
The heart of the matter: Right heart imaging indicators for treatment escalation in pulmonary arterial hypertensionPaul Forfia, Raymond Benza, Michele D'Alto, et al.
Heart (British Cardiac Society)|February 14, 2023
Pulmonary artery compliance in different forms of pulmonary hypertensionAmber McCormick, Amita Krishnan, David Badesch, et al.
Chest|June 6, 2021
Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry: Enrollment Characteristics and 1-Year Follow-upKim M Kerr, C Greg Elliott, Kelly Chin, et al.
Chest|August 18, 2024
Equivalency of Multiple Biomarkers to Clinical Pulmonary Arterial Hypertension Survival Risk ModelsMegan Griffiths, Catherine E Simpson, Jun Yang, et al.
Vascular Pharmacology|September 12, 2024
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensusGiovanna Manzi, Raymond L Benza, Paola Argiento, et al.
Chest|September 30, 2019
Retrospective Validation of the REVEAL 2.0 Risk Score With the Australian and New Zealand Pulmonary Hypertension Registry CohortJames J Anderson, Edmund M Lau, Melanie Lavender, et al.
Pulmonary Circulation|November 26, 2020
Residence at moderately high altitude and its relationship with WHO Group 1 pulmonary arterial hypertension symptom severity and clinical characteristics: the Pulmonary Hypertension Association RegistryShoaib Fakhri, Kelly Hannon, Kelly Moulden, et al.
Circulation|August 25, 2022
Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial HypertensionSamuel B Brusca, Jason M Elinoff, Yvette Zou, et al.
Journal for Immunotherapy of Cancer|August 25, 2021
Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphomaJonathan E Brammer, Zachary Braunstein, Aashish Katapadi, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2026
Circulating Biomarker Results From a Phase 2 Study of Seralutinib in Pulmonary Arterial HypertensionRobin Osterhout, Athénaïs Boucly, Raymond L Benza, et al.
Pageof 37